Similar articles

• Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.

  Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY. Chou YY, et al. J Microbiol Immunol Infect. 2008 Apr;41(2):124-9. J Microbiol Immunol Infect. 2008. PMID: 18473099
• Daptomycin for the treatment of vancomycin-resistant enterococcal infections.

  Grim SA, Hong I, Freeman J, Edwards C, Clark NM. Grim SA, et al. J Antimicrob Chemother. 2009 Feb;63(2):414-6. doi: 10.1093/jac/dkn478. Epub 2008 Nov 16. J Antimicrob Chemother. 2009. PMID: 19015143 No abstract available.
• [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].

  Klare I, Witte W. Klare I, et al. Wien Klin Wochenschr. 1997 May 9;109(9):293-300. Wien Klin Wochenschr. 1997. PMID: 9265387 Review. German. No abstract available.
• [Enterococcal infections. Clinical findings and treatment considering antibiotic resistance in Denmark].

  Olesen HV, Møller JK. Olesen HV, et al. Ugeskr Laeger. 2002 Apr 29;164(18):2386-90. Ugeskr Laeger. 2002. PMID: 12024841 Review. Danish.
• Emergence and management of drug-resistant enterococcal infections.

  Arias CA, Murray BE. Arias CA, et al. Expert Rev Anti Infect Ther. 2008 Oct;6(5):637-55. doi: 10.1586/14787210.6.5.637. Expert Rev Anti Infect Ther. 2008. PMID: 18847403 Review.